Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

By N. Wahlgren, N. Ahmed, A. Dávalos, G. Ford, M. Grond, W. Hacke, M. Hennerici, M. Kaste, Sonja Kuelkens, V. Larrue and 5 more. The Lancet, 2007

2,220 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. (2008, background): “Thrombolytic therapy appears to be safe and effective across various types of hospitals, if the diagnosis is established by a physician with stroke expertise and brain CT is assessed by an experienced physician [392-394].”
Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke (2018, positive): “—Symptomatic intracranial hemorrhage (SICH) is a parenchymal hematoma type II (per the Safe Implementation of Thrombolysis in Stroke Monitoring Study [SITSMOST] definition) (32) or subarachnoid hemorrhage (SAH) with neurologic deterioration leading to an increase in National Institutes of Health Str”